# Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin

> **NCT03259581** · PHASE1 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 5 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Bilirubinemia

## Interventions

- **COMBINATION_PRODUCT:** Transarterial chemoembolization

## Key facts

- **NCT ID:** NCT03259581
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-02
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-02-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2022-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03259581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03259581, "Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03259581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*